Clinical trials
Kidney Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 7 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Pfizer | 4 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
| Children's Oncology Group | 3 |
| Novartis Pharmaceuticals | 3 |
| University of Leicester | 2 |
| Actuate Therapeutics Inc. | 1 |
| Adhera Health, Inc. | 1 |
| Amgen | 1 |
| Amsterdam UMC, location VUmc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 40 |
| Carcinoma, Renal Cell | 20 |
| Neoplasms | 7 |
| Colorectal Neoplasms | 5 |
| Lung Neoplasms | 5 |
| Urinary Bladder Neoplasms | 5 |
| Wilms Tumor | 5 |
| Prostatic Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
Trials
Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.